226 related articles for article (PubMed ID: 25820146)
1. Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP).
Costa DD; Beghi E; Carignano P; Pagliacci C; Faccioli F; Pupillo E; Messina P; Gorio A; Redaelli T
Neurol Sci; 2015 Sep; 36(9):1567-74. PubMed ID: 25820146
[TBL] [Abstract][Full Text] [Related]
2. Investigation of efficacy of treatment in spinal cord injury: Erythropoietin versus methylprednisolone.
Ozkunt O; Sariyilmaz K; Gemalmaz HC; Gürgen SG; Yener U; Dikici F
J Orthop Surg (Hong Kong); 2017; 25(3):2309499017739481. PubMed ID: 29121822
[TBL] [Abstract][Full Text] [Related]
3. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III.
Bracken MB; Holford TR
J Neurosurg; 2002 Apr; 96(3 Suppl):259-66. PubMed ID: 11990832
[TBL] [Abstract][Full Text] [Related]
4. High-dose methylprednisolone for acute traumatic spinal cord injury: A meta-analysis.
Liu Z; Yang Y; He L; Pang M; Luo C; Liu B; Rong L
Neurology; 2019 Aug; 93(9):e841-e850. PubMed ID: 31358617
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin plus methylprednisolone or methylprednisolone in the treatment of acute spinal cord injury: a preliminary report.
Alibai E; Zand F; Rahimi A; Rezaianzadeh A
Acta Med Iran; 2014; 52(4):275-9. PubMed ID: 24901857
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection and acute spinal cord injury: a reappraisal.
Hall ED; Springer JE
NeuroRx; 2004 Jan; 1(1):80-100. PubMed ID: 15717009
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection of erythropoietin and methylprednisolone against spinal cord ischemia-reperfusion injury.
Xiong M; Chen S; Yu H; Liu Z; Zeng Y; Li F
J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):652. PubMed ID: 22038355
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of methylprednisolone in the acute phase of spinal cord injuries--a systematic review of randomized controlled trials].
Botelho RV; Daniel JW; Boulosa JL; Colli BO; Farias Rde L; Moraes OJ; Pimenta WE; Ribeiro CH; Ribeiro FR; Taricco MA; Carvalho MV; Bernardo WM
Rev Assoc Med Bras (1992); 2009; 55(6):729-37. PubMed ID: 20191229
[TBL] [Abstract][Full Text] [Related]
9. Methylprednisolone Therapy in Acute Traumatic Spinal Cord Injury: Analysis of a Regional Spinal Cord Model Systems Database.
Sunshine JE; Dagal A; Burns SP; Bransford RJ; Zhang F; Newman SF; Nair BG; Sharar SR
Anesth Analg; 2017 Apr; 124(4):1200-1205. PubMed ID: 28319547
[TBL] [Abstract][Full Text] [Related]
10. Pitfalls in treatment of acute cervical spinal cord injury using high-dose methylprednisolone: a retrospect audit of 111 patients.
Lee HC; Cho DY; Lee WY; Chuang HC
Surg Neurol; 2007; 68 Suppl 1():S37-41; discussion S41-2. PubMed ID: 17963919
[TBL] [Abstract][Full Text] [Related]
11. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.
Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings M; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W
JAMA; 1997 May; 277(20):1597-604. PubMed ID: 9168289
[TBL] [Abstract][Full Text] [Related]
12. Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury Registry.
Evaniew N; Noonan VK; Fallah N; Kwon BK; Rivers CS; Ahn H; Bailey CS; Christie SD; Fourney DR; Hurlbert RJ; Linassi AG; Fehlings MG; Dvorak MF;
J Neurotrauma; 2015 Nov; 32(21):1674-83. PubMed ID: 26065706
[TBL] [Abstract][Full Text] [Related]
13. [Methylprednisolone in the treatment of acute spinal cord injury has become more and more questioned].
Kronvall E; Sayer FT; Nilsson OG
Lakartidningen; 2005 Jun 13-26; 102(24-25):1887-8, 1890. PubMed ID: 16044768
[TBL] [Abstract][Full Text] [Related]
14. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.
Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings MG; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W
J Neurosurg; 1998 Nov; 89(5):699-706. PubMed ID: 9817404
[TBL] [Abstract][Full Text] [Related]
15. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care.
Hurlbert RJ
J Neurosurg; 2000 Jul; 93(1 Suppl):1-7. PubMed ID: 10879751
[TBL] [Abstract][Full Text] [Related]
16. The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats.
Cetin A; Nas K; Büyükbayram H; Ceviz A; Olmez G
Eur Spine J; 2006 Oct; 15(10):1539-44. PubMed ID: 16547753
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings.
Kaptanoglu E; Solaroglu I; Okutan O; Surucu HS; Akbiyik F; Beskonakli E
Neurosurg Rev; 2004 Apr; 27(2):113-20. PubMed ID: 12920606
[TBL] [Abstract][Full Text] [Related]
18. Changes in the use of the methylprednisolone protocol for traumatic spinal cord injury in Switzerland.
Felleiter P; Müller N; Schumann F; Felix O; Lierz P
Spine (Phila Pa 1976); 2012 May; 37(11):953-6. PubMed ID: 22020592
[TBL] [Abstract][Full Text] [Related]
19. A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.
Martinelli V; Rocca MA; Annovazzi P; Pulizzi A; Rodegher M; Martinelli Boneschi F; Scotti R; Falini A; Sormani MP; Comi G; Filippi M
Neurology; 2009 Dec; 73(22):1842-8. PubMed ID: 19949030
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
